NEW YORK (GenomeWeb) – The United States Court of Appeals for the Federal Circuit this week handed down a ruling in the case of Roche Molecular Systems, Inc. v. Cepheid affirming a district court's previous ruling invalidating a US patent assigned to Roche covering PCR-based methods for detecting Mycobacterium tuberculosis (MTB) and drug resistance.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.